Cargando…
Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
Gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the alimentary tract and are believed to derive from the interstitial Cell of Cajal. Imatinib mesylate (Gleevec(®); Novartis, Basel, Switzerland) has revolutionized the treatment of GISTs and is generally used in the metastatic a...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661077/ https://www.ncbi.nlm.nih.gov/pubmed/19291285 http://dx.doi.org/10.1186/1477-7819-7-30 |